Jaume Pons

CIK: 0001816977

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)2 (66.7%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (33.3%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

ALXO

ALX ONCOLOGY HOLDINGS INC

Officer

Discretionary Trading P&L

Holdings

Transaction History (3 total)

ALXO
ALX ONCOLOGY HOLDINGS INC
Feb 19, 2025
Sale(S)
Direct
1.3K shares at avg. $1.15$2K
ALXO
ALX ONCOLOGY HOLDINGS INC
Jan 21, 2025
Award(A)
Employee Stock Option (right to buy)
Direct
50K shares-
ALXO
ALX ONCOLOGY HOLDINGS INC
Dec 30, 2024
Sale(S)
Direct
10.8K shares at avg. $1.58$17K

		Type	Shares	Price		Ownership
Feb 19, 2025	ALXO ALX ONCOLOGY HOLDINGS INC	Sale(S)	1,326	$1.15	$1,525	Direct
Jan 21, 2025	ALXO ALX ONCOLOGY HOLDINGS INC	Award(A) Employee Stock Option (right to buy)	50,000	-	-	Direct
Dec 30, 2024	ALXO ALX ONCOLOGY HOLDINGS INC	Sale(S)	10,796	$1.58	$17,060	Direct

1-3 of 3 transactions

About Pons Jaume

Pons Jaume (SEC CIK 0001816977) files insider reports with the SEC as PRESIDENT & CSO of ALX ONCOLOGY HOLDINGS INC (ALXO).

Signal8 holds 3 ownership filings by Pons Jaume, all Form 4s, filed between Jan 2, 2025 and Feb 21, 2025. Those filings report 3 transactions, from Dec 30, 2024 to Feb 19, 2025. Signal8's Form 4 history starts in Sep 2024.

The business address on Pons Jaume's filings is in SOUTH SAN FRANCISCO, CA.

Recent filings by Pons Jaume

Feb 19, 2025: Open-market sale of ALXO shares (Form 4, code S).
Jan 21, 2025: Grant or award of ALXO derivative securities (Form 4, code A).
Dec 30, 2024: Open-market sale of ALXO shares (Form 4, code S).

Other insiders filing for ALX ONCOLOGY HOLDINGS INC (ALXO)

Lettmann Jason, CHIEF EXECUTIVE OFFICER
Wong Shelly, SVP, FINANCE AND CAO
Knight Jeff E., Chief Dev & Operating Officer
Klencke Barbara, Chief Medical Officer
GOODMAN COREY S, Director
Shantharam Harish, Chief Financial Officer

How to read Form 4 transaction codes